Burcu Darst

Affiliate Assistant Professor, Epidemiology



PhD Epidemiology, University of Wisconsin (Madison), 2018
BS Cognitive Science, University of California (San Diego), 2009



Office M4-B873
1100 Fairview Ave N
Seattle, WA 98109
View Website »


Dr. Burcu Darst’s is a genetic epidemiologist with research focused on identifying and understanding genetic and multi-omic risk factors of complex diseases in diverse populations, particularly how they relate to health disparities. Her research lies predominantly in studying prostate cancer, type 2 diabetes, and Alzheimer’s disease, with the underlying goal of identifying risk factors that could prevent the onset and health disparities of these diseases. Dr. Darst’s research is based on a variety of approaches, including using rare genetic variants captured with genomic sequencing, genome-wide association studies, polygenic risk scores, and metabolomics to understand disease risk. Currently, she is leading an effort to improve understanding of the genomic and metabolic mechanisms contributing to prostate cancer risk in men from diverse populations as well as improving the utility of polygenic risk scores and rare genetic variants for the prediction of prostate cancer across multi-ancestry patient populations.This research is conducted in collaboration with large-scale international collaborations investigating genetic risk of prostate cancer.

Research Interests

Prostate cancer prevention, Health disparities, Genetic risk factors, Molecular biomarkers, Multi-omic integration

Recent Publications (PubMed)

Genetic variants associated with post-traumatic stress symptoms in patients with gynecologic cancer.
(2023 Jan 19)
Gynecol Oncol 170(): 102-107
Johnson AM, Teoh D, Jewett P, Darst BF, Mattson J, Hoffmann C, Brown K, Makaram A, Keller C, Blaes AH, Everson-Rose SA, Vogel RI

Research silos in cancer disparities: obstacles to improving clinical outcomes for under-served patient populations.
(2023 Jan 13)
Clin Cancer Res
Richardson A, Darst B, Wojcik G, Wagle N, Haricharan S

RE: Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program.
(2023 Jan 11)
J Natl Cancer Inst
Haiman CA, Kote-Jarai Z, Darst BF, Conti DV

Association of Prostate-Specific Antigen Levels with Prostate Cancer Risk in a Multiethnic Population: Stability Over Time and Comparison with Polygenic Risk Score.
(2022 Dec 5)
Cancer Epidemiol Biomarkers Prev 31(12): 2199-2207
Chou A, Darst BF, Wilkens LR, Marchand LL, Lilja H, Conti DV, Haiman CA

Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa.
(2022 Sep 13)
Genome Biol 23(1): 194
Kim MS, Naidoo D, Hazra U, Quiver MH, Chen WC, Simonti CN, Kachambwa P, Harlemon M, Agalliu I, Baichoo S, Fernandez P, Hsing AW, Jalloh M, Gueye SM, Niang L, Diop H, Ndoye M, Snyper NY, Adusei B, Mensah JE, Abrahams AOD, Biritwum R, Adjei AA, Adebiyi AO, Shittu O, Ogunbiyi O, Adebayo S, Aisuodionoe-Shadrach OI, Nwegbu MM, Ajibola HO, Oluwole OP, Jamda MA, Singh E, Pentz A, Joffe M, Darst BF, Conti DV, Haiman CA, Spies PV, van der Merwe A, Rohan TE, Jacobson J, Neugut AI, McBride J, Andrews C, Petersen LN, Rebbeck TR, Lachance J

Show complete publication list

In the News

No news articles at this time.